Vision Research

A broad spectrum of funding sources, from individual donations to National Institutes of Health grants, enables our researchers to take a multidisciplinary approach to improving the fundamental understanding, diagnosis and management of eye diseases. As a leader in clinical and translational research, Vision Science Research at MCW supports a solid platform for innovation, collaboration and discovery.  Learn more about our Corporate Ventures.

Advanced Ocular Imaging Program (AOIP)

The Advanced Ocular Imaging Program (AOIP), located in the Eye Institute, serves as a local, national, and international resource for advancing the field of ocular imaging and for translating adaptive optics technology into a clinically relevant imaging tool. More information about this program is available on the AOIP website.

Ocular Gene Therapy

The Ocular Gene Therapy Laboratory (OGTL), founded by Daniel M. Lipinski, MSc, DPhil, and located in the Eye Institute, aims to develop broadly applicable gene-based therapeutics to prevent human blindness arising from neurodegenerative or vascular diseases affecting the retina. More information about this lab is available on the OGTL website.



We are fortunate to have a diverse array of funding sources for our research at the Eye Institute. We would like to acknowledge the National Institutes of Health (NIH), the National Eye Institute (NEI), Research to Prevent Blindness, and the R.D. & Linda Peters Foundation for their long-term support of our research projects.  We also gratefully thank the many other local and national foundations who have made contributions to advance our mission. Finally, with all of our hearts, we thank our patients for their philanthropic donations, which provide especially vital support for new projects and continued innovation.